(Q55052510)

English

Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

object named as

Kok Hian Tan

17

0 references

object named as

Chuen Neng Lee

13

0 references

Gerard Pasterkamp

15

object named as

Gerard Pasterkamp

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

Dominique de Kleijn

16

object named as

Dominique P V de Kleijn

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

18

object named as

Sai Kiang Lim

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

1

object named as

Ruenn Chai Lai

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

5

object named as

Andre Choo

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Reida Menshawe El Oakley

14

object named as

Reida Menshawe El Oakley

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

author name string

Fatih Arslan

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Soon Sim Tan

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Betty Tan

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

May May Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Tian Sheng Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Bao Ju Teh

8

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

John Kun Long Eng

9

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Harwin Sidik

10

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Vivek Tanavde

11

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Wei Sek Hwang

12

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

publication date

11 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

48

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

1215-1224

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Mesenchymal stem cells: progress toward promise

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells and the treatment of cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells for cardiac regenerative therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Advances in cell-based therapy for structural heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Optimizing adult mesenchymal stem cells for heart repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Opportunities and challenges for mesenchymal stem cell-mediated heart repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Intestinal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Membrane vesicles as conveyors of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells: paradoxes of passaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Mesenchymal stem cells: clinical applications and biological characterization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Characterization and functionality of cell surface molecules on human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Circulating microparticles in normal pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Tissue factor-bearing microparticles and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Microparticles, thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Cell-derived microparticles in haemostasis and vascular medicine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Endothelial microparticles in diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Potential roles of cell-derived microparticles in ischemic brain disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Basic mechanisms and pathogenesis of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Microparticles and thrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Microvesicles: messengers and mediators of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Cell-derived microparticles: a new challenge in neuroscience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

The coagulopathy of acute promyelocytic leukaemia revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Tissue factor and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

The role of innate immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Therapeutic potential of plasma membrane-derived microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.12.021

7 January 2021

Identifiers

10.1016/J.YJMCC.2009.12.021

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

release_iu3czmfwvvc3pb4pjcu6a2ddae

1 reference

https://api.fatcat.wiki/v0/release/iu3czmfwvvc3pb4pjcu6a2ddae

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/20064522

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55052510&oldid=1835626331"